Genetic engineering, also called genetic modification or genetic manipulation, is the direct manipulation of an organism's genes using biotechnology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms.
The Genetic Engineering market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Genetic Engineering industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Genetic Engineering market can be split based on product types, major applications, and important countries as follows:
Key players in the global Genetic Engineering market covered in Chapter 12:
New England Biolabs
Integrated DNA Technologies
Transposagen Biopharmaceuticals, Inc.
Amgen Inc.
Sangamo Therapeutics, Inc.
Genentech, Inc.
Horizon Discovery Group plc
Thermo Fisher Scientific Inc.
Lonza Group Ltd.
OriGene Technologies, Inc.
Merck KGaA
GenScript
Others
In Chapter 4 and 14.1, on the basis of types, the Genetic Engineering market from 2015 to 2025 is primarily split into:
DNAase
Metazoans
Micrococcal nuclease
Metazoans
RNase A
RNase H
RNase III,
RFLP (Restriction Fragment Length Polymorphism)
AFLP (Amplified Fragment Length Polymorphism)
SSLP (Simple sequence length polymorphism)
Others
In Chapter 5 and 14.2, on the basis of applications, the Genetic Engineering market from 2015 to 2025 covers:
Agriculture
Medical industry
Forensic science
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Genetic Engineering. Industry analysis & Market Report on Genetic Engineering is a syndicated market report, published as COVID-19 Outbreak-Global Genetic Engineering Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020. It is complete Research Study and Industry Analysis of Genetic Engineering market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.